Trial intelligence / Profile preview

Effect of Oral Sodium Bicarbonate Supplementation on Urine TGF-beta in CKD with Normal Serum Bicarbonate

TCTR20240817007Phase 3Completed

Sponsor
Department of Medicine, Phramongkutklao Hospital
Start
Nov 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sodium bicarbonate in chronic kidney disease (CKD), sponsored by Department of Medicine, Phramongkutklao Hospital. Started Nov 2023; status: completed.

02

Drugs

sodium bicarbonate
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on TCTR20240817007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240817007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call